FAQs

When was the company founded?

The Company was founded in 2011 in Delaware based on technology developed in Israel.

How many employees does DarioHealth have?

The company currently has 165 full-time employees.

How can I obtain copies of DarioHealth financial reports, or request an investor kit or annual report?

Financial reports are available in the “SEC Filings” page of the “Investors” section of the company’s website.

Where can I find DarioHealth’s latest investor presentation?

DarioHealth’s most recent investor presentation is available on the “Investors” section on the company’s website.

Financial Reporting & Stock Information:

When is DarioHealth’s fiscal year end?

The fiscal year ends on December 31.

Where is DarioHealth’s stock traded?

The stock is traded on the NASDAQ under the symbol DRIO.

Does DarioHealth pay dividends on its common stock?

DarioHealth has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.

External Advisors and Contact Information:

Who are DarioHealth’s independent auditors?

Kesselman & Kesselman
A Member of PricewaterhouseCoopers International Limited
14 Derech Menachem Begin St
Tel Aviv, Israel 6492103

Who do I contact to request information on my account or change my account information?

Questions regarding stock holdings, certificate replacement/transfer and address changes should be directed to our Transfer Agent:

VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516
Attention: Yoel Goldfeder
Phone:  212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179

Who is DarioHealth’s outside corporate counsel?

Sullivan & Worcester LLP
1251 Avenue of the Americas
19th Floor
New York, NY 10020
Phone: 212 660 3000
https://www.sullivanlaw.com/

How do I contact DarioHealth’s Investor Relations?

Please call +1-201-785-6310 or send an email to irteam@dariohealth.com.